An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Nanoparticles (NPs) are promising drug delivery systems (DDS) for identifying and treating cancer. Active targeting NPs can be generated by conjugation with ligands that bind overexpressed or mutant cell surface receptors on target cells that are poorly or not even expressed on normal cells. Recepto...
Saved in:
Main Authors: | Alberto Juan (Author), Francisco J. Cimas (Author), Iván Bravo (Author), Atanasio Pandiella (Author), Alberto Ocaña (Author), Carlos Alonso-Moreno (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer
by: Francisco J. Cimas, et al.
Published: (2020) -
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
by: Zar Chi Soe, et al.
Published: (2019) -
Medicinal Plants as Sources of Active Molecules Against COVID-19
by: Bachir Benarba, et al.
Published: (2020) -
Evaluation of polymeric PLGA nanoparticles conjugated to curcumin for use in aPDT
by: Renata Celi Carvalho de Souza Pietra, et al.
Published: (2017) -
Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency
by: Indra Van Zundert, et al.
Published: (2021)